94 related articles for article (PubMed ID: 3209918)
21. [Study on adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
Kikkawa N; Kawahara T
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1881-5. PubMed ID: 3382240
[TBL] [Abstract][Full Text] [Related]
22. [Immunochemotherapy using OK-432 in gestational choriocarcinoma].
Kanazawa K; Ohno M; Takeuchi S
Nihon Gan Chiryo Gakkai Shi; 1982 Oct; 17(7):1902-7. PubMed ID: 6891714
[No Abstract] [Full Text] [Related]
23. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
Marumo K; Mura M; Deguchi N; Baba S; Jitsukawa S; Nakazono M; Tazaki H
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2434-9. PubMed ID: 3729498
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
[No Abstract] [Full Text] [Related]
25. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
[No Abstract] [Full Text] [Related]
26. [Investigation on the adequate administration interval with OK-432, using the cytotoxicity test].
Tsukuda M; Furukawa S; Yoshida T; Yanoma S; Watanabe A; Takahashi K; Ono T; Sawaki S
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):423-5. PubMed ID: 2930206
[No Abstract] [Full Text] [Related]
27. [The clinical effect of concomitant use of non-specific immunopotentiator OK-432 on primary lung cancer treated with radiation combined with chemotherapy].
Ogawa Y; Kimura S; Imajo Y; Imanaka K; Gose K
Nihon Gan Chiryo Gakkai Shi; 1982 Oct; 17(7):1949-56. PubMed ID: 7161555
[No Abstract] [Full Text] [Related]
28. [Cytologic changes following intratumoral high dose injection of OK-432 in advanced pancreatic cancers and gall bladder cancers with ultrasound guidance].
Okano Y; Takenaka A; Kasugai H; Morii T; Kishigami Y; Okuda S
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1892-3. PubMed ID: 6882009
[No Abstract] [Full Text] [Related]
29. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of intratumoral injection of an immunopotentiator (OK-432) in patients with hepatocellular carcinoma].
Imaoka S; Sasaki Y; Matsui Y; Ishikawa O; Taniguchi K; Iwanaga T; Terasawa T
Nihon Gan Chiryo Gakkai Shi; 1982 Oct; 17(7):1957-62. PubMed ID: 6298326
[No Abstract] [Full Text] [Related]
31. [Treatment of T-cell lymphoma with immunotherapy of OK-432--a case report (author's transl)].
Nakayama S; Tsuji K; Kitajima K; Ueno K; Hoshino T
Rinsho Ketsueki; 1980 Jan; 21(1):66-72. PubMed ID: 6966340
[No Abstract] [Full Text] [Related]
32. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
[No Abstract] [Full Text] [Related]
34. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
[TBL] [Abstract][Full Text] [Related]
35. [Endoscopic administration of OK-432 in gastric cancer].
Inbe A; Sumii K; Haruma K; Uemura N; Tari A; Yoshihara M; Tokutomi T; Inaba Y; Sekito M; Ogoshi H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):514-9. PubMed ID: 3954375
[TBL] [Abstract][Full Text] [Related]
36. [The clinical value of long-term administration of OK-432 in head and neck cancer].
Mitarai K; Tsukuda M; Tamamushi N; Mochimastu I; Kubota A; Sawaki S
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):945-50. PubMed ID: 3963858
[TBL] [Abstract][Full Text] [Related]
37. [Combination therapy of large amount of carboquone and OK-432 for unresectable lung cancer].
Nakarai I; Honda T; Jinnai S; Kita T; Shinoda A
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1006-11. PubMed ID: 7184436
[TBL] [Abstract][Full Text] [Related]
38. [A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study].
Yamamura Y; Yasue M; Nakazato H; Ota K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):541-8. PubMed ID: 3923941
[TBL] [Abstract][Full Text] [Related]
39. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
[TBL] [Abstract][Full Text] [Related]
40. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
